Document is current
Any future updates will be listed below
-
Authors
Tie, Xin
Shin, Muheon
Pirasteh, Ali
Ibrahim, Nevein
Huemann, Zachary
Castellino, Sharon M.
Kelly, Kara M.
Garrett, John
Hu, Junjie
Cho, Steve Y.
Bradshaw, Tyler J. https://orcid.org/0000-0001-9549-7002
-
Funding
Funding for this research was provided by:
Imaging and Radiology Oncology Core Rhode Island (U24CA180803)
Biomarker, Imaging and Quality of Life Studies Funding Program
NCTN Operations Center Grant (U10CA180886)
NCTN Statistics and Data Center Grant (U10CA180899)
St. Baldrick’s Foundation
National Institute of Biomedical Imaging and Bioengineering (R01EB033782)
- License Information
-
More Information
Article History
Received: 6 December 2023
Revised: 17 January 2024
Accepted: 18 January 2024
First Online: 2 February 2024
Declarations
:
: Institutional Review Board approval was obtained. Informed consent was waived by IRB due to minimal risk to subjects.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
: Dr. Sharon M. Castellino is on SeaGen Inc. advisory board (no honorarium); Bristol Meyers Squibb advisory board; MJH Health Sciences – CME sponsored speaker. Dr. Ali Pirasteh receives Departmental Research Support from GE Healthcare and Bracco Diagnostics. No products from any of the aforementioned companies were used in this study. Other authors have no relevant conflicts of interest to declare.
